TAE Technologies logo

TAE Technologies

APrivate (proposed TMTG merger; targeted Q4 2026 close)Founded 1998🇺🇸Foothill Ranch, California
CEO

Michl Binderbauer

Data verified as of Jul 20, 2026

Summary

TAE Technologies is a private fusion company developing hydrogen-boron fusion with a beam-driven field-reversed-configuration architecture. Its 2025 'Norm' breakthrough reduced reactor complexity enough to skip the planned Copernicus step and move directly toward Da Vinci, its first prototype power plant. In 2026 TAE completed its multi-state site evaluation tour for the first 50 MWe plant (Alabama, Ohio, Texas), formally established the TAE Beam UK joint venture with UKAEA at Culham to commercialize neutral-beam accelerator technology, and is now targeting a Q4 2026 close of its $6B all-stock merger with Trump Media & Technology Group, which in June 2026 confirmed it will no longer spin off Truth Social and other media assets ahead of the deal. TAE Power Solutions and TAE Life Sciences commercialize adjacent power-delivery and oncology technologies derived from its fusion R&D.

Main Products

Norm

Norm

Operational

TAE's streamlined fusion research machine that forms field-reversed-configuration plasmas using only neutral beam injection, reducing reactor size, complexity, and cost versus Norman while preserving the path to commercial hydrogen-boron fusion.

Operational in Foothill Ranch, California. Norm routinely delivers TAE's highest plasma performance and is being upgraded to 100 million degrees Celsius.

Plasma Temperature70+ million °C
Machine Length~12 m / 40 ft
ConfigurationNBI-only FRC
Da Vinci

Da Vinci

In Development (siting)

TAE's first prototype commercial fusion power plant, designed to deliver net electrons to the grid from the company's hydrogen-boron fusion pathway and serve as the bridge to later utility-scale plants.

Pre-construction. TAE completed its multi-state site-evaluation tour across Alabama, Ohio, and Texas on April 7, 2026 and is finalizing site selection. Construction is expected to begin after required approvals and the closing of the proposed TMTG merger, which a June 10, 2026 update reset to a Q4 2026 (or sooner) target. Grid delivery remains targeted for the early 2030s.

Target Output50 MWe
Future Plant Scale350-500 MWe
Target OperationEarly 2030s

What's Next

Close the proposed TMTG merger and file Form S-4

File the still-pending Form S-4 with the SEC (unlocks an additional $100M of TMTG cash for TAE on top of the $200M provided at signing), then obtain TMTG shareholder and regulatory approvals to close the all-stock merger — a June 10, 2026 update pushed the target to Q4 2026 or sooner and dropped the earlier plan to spin off Truth Social — and fund Da Vinci construction.

Q4 2026 (or sooner)

Pick the first plant site and start construction

Convert the April 7, 2026 completion of the Alabama/Ohio/Texas site evaluation tour into a final site choice and start construction of the initial ~50 MWe Da Vinci facility, contingent on the TMTG merger close (now targeted Q4 2026 or sooner) and approvals. As of mid-July 2026 no final site had been announced.

2026

Upgrade Norm to 100 million °C

Push the current experimental platform from 70+ million °C — already the highest temperature recorded on a steady-state FRC — toward 100 million °C to validate operating modes and hardware for TAE's next-generation reactors.

2026–2027

Stand up TAE Beam UK and deliver first short-pulse beams

Operationalize the newly funded UKAEA joint venture at Culham, hire its neutral-beam program team, and deliver the first short-pulse beams within 18–24 months of program start (target ~late 2027 to mid-2028).

2027–2028

Da Vinci grid power delivery

Deliver first fusion-generated electricity to the grid from the ~50 MWe Da Vinci prototype plant, establishing TAE as a commercial fusion power provider, with follow-on plants scaling to 350–500 MWe.

Early 2030s

Recent News

View all →

Operations & Revenue

StatusPre-revenue in fusion; merger pending

Norm is operational and being upgraded toward 100 million °C, while TAE has completed multi-state site evaluation (Alabama, Ohio, Texas) for its first ~50 MWe Da Vinci plant. As of a June 10, 2026 update, the proposed $6B all-stock merger with Trump Media & Technology Group now targets a Q4 2026 close (or sooner) subject to shareholder and regulatory approvals, and the parties have dropped the previously discussed spin-off of TMTG media assets including Truth Social; TMTG has provided $200M cash at signing with a further $100M available on Form S-4 filing, which remains to be filed. The TAE Beam UK joint venture with UKAEA was formally established at Culham on May 14, 2026.

Revenue Streams

TAE Power Solutions

Subsidiary commercializing power-delivery and battery energy-storage systems originally built for TAE's fusion program, including EV powertrains and stationary storage applications. In June 2026 it made its first field deployment, shipping a hybrid battery-plus-ultracapacitor storage prototype to MARA Holdings for grid-responsive load management at data-center scale, with production deployments planned later in 2026.

TAE Life Sciences

Subsidiary developing boron neutron capture therapy (BNCT) platforms and related drugs for complex cancers using accelerator technology adapted from TAE's fusion R&D. April 2026 peer-reviewed research showed its next-generation BPA-dipeptide boron-delivery compounds achieved 12–77x higher solubility than standard BPA and complete, durable tumor regressions in preclinical models.

TAE Beam UK (UKAEA joint venture)

Joint venture with the UK Atomic Energy Authority formally established May 14, 2026 at UKAEA's Culham Campus. Develops neutral-beam particle accelerators for fusion (TAE's own multi-year demand plus third-party fusion approaches) and adapts the technology for cancer therapeutics, food safety, and other non-fusion applications. UKAEA equity investment: £5.6M; TAE backstops with a nine-figure investment. First short-pulse beams targeted within 18–24 months.

Key Metrics

Employees

~400

Est. Annual Revenue

Pre-revenue in fusion; near-term commercialization centered on TAE Power Solutions and TAE Life Sciences. $200M TMTG cash injection at signing plus an additional $100M conditional on Form S-4 filing (S-4 not yet filed as of mid-July 2026).

Total Funding

>$1.3B equity raised since inception (plus $200M TMTG cash at signing, additional $100M upon S-4 filing)

Proposed TMTG Merger Value

$6B+ all-stock; ~50/50 fully-diluted equity split; targeted Q4 2026 close (or sooner); Form S-4 still not filed as of mid-July 2026

Granted Patents

>1,600

Norm Plasma Temperature

70+ million °C (steady-state FRC; upgrade to 100M °C underway)

Da Vinci Initial Output

~50 MWe (early 2030s); follow-on plants 350–500 MWe

TAE Beam UK Funding

£5.6M UKAEA equity + TAE nine-figure investment

Timeline

2026TMTG and TAE commence joint site-selection planning

On January 6, 2026, Trump Media & Technology Group and TAE announce the site-selection planning process is underway for the first utility-scale fusion power plant. Following required approvals and merger close, the combined company is anticipated to begin construction in 2026 on a ~50 MWe facility, with follow-on plants scaling to 350–500 MWe.

2026Cedric Burgher joins as CFO

On February 27, 2026, TAE names Cedric Burgher Chief Financial Officer. Burgher previously served as CFO of Occidental Petroleum, QR Energy, and KBR; at TAE he will oversee accounting, capital markets, treasury, and investor relations and focus on scaling public-company processes ahead of the proposed TMTG merger.

2026Multi-state site evaluation tour completed

On April 7, 2026, TAE announces it has completed its multi-state site evaluation tour across Alabama, Ohio, and Texas for its first 50 MWe fusion power plant. The leadership team (Binderbauer, CFO Burgher, TAE Global GmbH CEO Jonathan Toretta) met with state and local officials and assessed infrastructure readiness, grid connectivity, land access, workforce availability, transportation access, and incentives.

2026TAE Life Sciences publishes BNCT boron-delivery breakthrough

On April 7, 2026 TAE Life Sciences announced peer-reviewed research in ACS Pharmacology & Translational Science on a next-generation boron-delivery platform for boron neutron capture therapy (BNCT). Its proprietary BPA-dipeptide compounds showed 12–77x higher solubility than standard boronophenylalanine and, in preclinical models, drove complete and durable tumor regressions — including a 100% complete-response rate in a human head-and-neck cancer xenograft — plus evidence of a systemic anti-tumor immune effect, advancing TAE's accelerator-based oncology business.

2026TAE Beam UK joint venture formally established

On May 14, 2026, TAE and the UK Atomic Energy Authority announce that their TAE Beam UK joint venture is formally established and fully funded. UKAEA is making a £5.6M equity investment, TAE is backstopping with a nine-figure investment, and the venture is based at UKAEA's Culham Campus in Oxfordshire. It will develop neutral beams for fusion plus adapted accelerator technology for cancer therapeutics, food safety, and other applications, with first short-pulse beams targeted within 18–24 months.

2026TMTG merger reset to Q4 2026 close; Truth Social spin-off dropped

On June 10, 2026, TAE and Trump Media & Technology Group said they now aim to close their ~$6B all-stock merger in the fourth quarter of 2026 or sooner, moving the target out from the originally signaled mid-2026 window. The companies also confirmed they will no longer pursue a previously discussed spin-off of TMTG media assets including Truth Social, with the combined company's board to weigh strategic alternatives for legacy units after closing. A Form S-4 registration statement to register the TMTG shares issued in the merger remains to be filed.

2026Jeff Woodbury named President and COO

On June 17, 2026, TAE appoints Jeff Woodbury as President and Chief Operating Officer to support commercial fusion deployment. Woodbury spent roughly 35 years at ExxonMobil, holding senior roles overseeing large-scale operations, major capital projects and global upstream activities, most recently as a corporate vice president and officer. He joins as TAE advances site selection and design for its first utility-scale fusion power plant, an initial ~50 MWe facility targeted for the early 2030s.

2026TAE Power Solutions ships first hybrid storage prototype to MARA

On June 30, 2026 TAE Power Solutions shipped its first hybrid energy-storage prototype — pairing battery cells, ultracapacitors, and high-speed power electronics derived from TAE's fusion program — to MARA Holdings (NASDAQ: MARA) for field validation at a MARA site. It is the first field deployment under the companies' 2025 collaboration on grid-responsive load management for power-intensive digital infrastructure, with additional production deployments planned later in 2026 — an early commercial proof point for TAE's non-fusion revenue lines.

2025Norm breakthrough published

TAE publishes its Nature Communications breakthrough showing FRC plasma formation using only neutral beam injection, creating the simpler 'Norm' machine.

2025Latest funding round

Raises more than $150M from investors including Chevron Technology Ventures, Google, and NEA, taking total equity capital raised since inception to more than $1.3B.

2025Copernicus removed from roadmap

TAE says Norm's performance is strong enough to leapfrog the planned Copernicus machine and move directly toward Da Vinci.

2025TMTG merger announced

TAE signs a definitive agreement to merge with Trump Media & Technology Group in an all-stock transaction valued at more than $6B, subject to approvals and closing conditions.

2022Norman exceeds goals by 250%

TAE says Norman sustained plasma above 75 million degrees Celsius, 250% above its original goal, while closing a $250M Series G-2 round.

2021$280M financing after 50M+ C milestone

TAE raises an additional $280M after demonstrating stable plasmas above 50 million degrees Celsius on Norman.

2017Norman first plasma

TAE's fifth-generation C-2W machine, later named Norman, achieves first plasma as the company continues its transition from Tri Alpha Energy to TAE Technologies.

2015Plasma confinement milestone

TAE says its C-2U machine kept an FRC plasma confined at operator will, validating the 'long enough' part of its fusion roadmap.

1998Founded as Tri Alpha Energy

Founded in 1998 as Colliding Beam Fusion Reactor Inc., later operating as Tri Alpha Energy before becoming TAE Technologies.

Funding

Cumulative disclosed raise · dated rounds

$250M$500M$750M2022202320242025$680M raised
RoundDateAmountInvestorsSource
Funding Round2021$280MGoogle, NEA, and other new and existing investors
Series G-22022$250MGoogle, Chevron, Reimagined Ventures, Sumitomo Corporation of Americas, TIFF Investment Management, and others
Funding Round2025>$150MGoogle, Chevron Technology Ventures, NEA